Skip to main content
Fig. 7 | Molecular Cancer

Fig. 7

From: MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2

Fig. 7

miR-25-3p functioned through BTG2 in AKT and ERK MAPK signaling pathway. a, b. western blot for BTG2, AKT, p-AKT, ERK1/2 and p-ERK1/2 in MDA-MB-231 and Sum-1315 cells transfected with inhibitor-control (inhibitor-ctrl) and siBTG2 scrambled oligonucleotide (si-ctrl), inhibitor and si-ctrl, inhibitor and siBTG2, or inhibitor-ctrl and siBTG2. Protein expression was quantified by band intensity and normalized to GAPDH. *p < 0.05, **p < 0.01. The data expressed as the mean ± SD

Back to article page